Skip to content

Serotonin and resilience to trauma-related exposure in serotonin reuptake inhibitor-recovered posttraumatic stress disorder

Tryptophan depletion paradigm increases the subjective and physiological responses to trauma-related stimuli in selective serotonin reuptake inhibitors-recovered patients with posttraumatic stress disorder

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12608000531314
Enrollment
10
Registered
2008-10-15
Start date
2006-02-14
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Selective serotonin reuptake inhibitors are the first-line treatment for posttraumatic stress disorder but their mechanism of action is unclear. Though an effect on stress resilience is postulated Serotonin helps regulate stress responses in other anxiety disorders. The main objective of this study is to examine the role of serotonin in resilience to trauma-related exposure through tryptophan depletion paradigm. Our main hypothesis hypothesis is that exposure to trauma-related stimuli leads to greater subjective and physiological responses under acute tryptophan depletion than under control conditions.

Interventions

Acute tryptophan depletion through the ingestion of a amino acid mixture without triptophan (100g), which stimulates the liver to produce proteins and leads to competition to cross the blood-brain barrier. This mixture is administered only twice: in the morning of the test day and in the morning of the control day (both at 9.30 a.m.). The mixture was orally administered. Its effects are rapidly reversed with reinstatement of the normal alimentation so the week between test and control procedures

Acute tryptophan depletion through the ingestion of a amino acid mixture without triptophan (100g), which stimulates the liver to produce proteins and leads to competition to cross the blood-brain barrier. This mixture is administered only twice: in the morning of the test day and in the morning of the control day (both at 9.30 a.m.). The mixture was orally administered. Its effects are rapidly reversed with reinstatement of the normal alimentation so the week between test and control procedures functions as wash-out period.

Sponsors

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Posttraumatic stress disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria; make good response to a selective serotonin reuptake inhibitors (cllinical dose ajusted)

Exclusion criteria

Comorbid bipolar disirder, psychotic disorder, substance misuse disorder, major madical condition and (or) the use of other psychiatric medication

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026